These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 22209153)

  • 41. Five-year analysis of treatment efficacy and cosmesis by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation.
    Vicini F; Beitsch P; Quiet C; Gittleman M; Zannis V; Fine R; Whitworth P; Kuerer H; Haffty B; Keisch M; Lyden M
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):808-17. PubMed ID: 20472364
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Late toxicity and patient self-assessment of breast appearance/satisfaction on RTOG 0319: a phase 2 trial of 3-dimensional conformal radiation therapy-accelerated partial breast irradiation following lumpectomy for stages I and II breast cancer.
    Chafe S; Moughan J; McCormick B; Wong J; Pass H; Rabinovitch R; Arthur DW; Petersen I; White J; Vicini FA
    Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):854-9. PubMed ID: 23726000
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Accelerated partial breast irradiation with iridium-192 multicatheter PDR/HDR brachytherapy. Preliminary results of the German-Austrian multicenter trial.
    Ott OJ; Pötter R; Hammer J; Hildebrandt G; Lotter M; Resch A; Pöhls U; Beckmann MW; Sauer R; Strnad V
    Strahlenther Onkol; 2004 Oct; 180(10):642-9. PubMed ID: 15480513
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term outcome and toxicity in a Phase I/II trial using high-dose-rate multicatheter interstitial brachytherapy for T1/T2 breast cancer.
    Kaufman SA; DiPetrillo TA; Price LL; Midle JB; Wazer DE
    Brachytherapy; 2007; 6(4):286-92. PubMed ID: 17991625
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cosmetic outcome and incidence of infection with the MammoSite breast brachytherapy applicator.
    Dickler A; Kirk MC; Choo J; Hsi WC; Chu J; Dowlatshahi K; Francescatti D; Shott S; Nguyen C
    Breast J; 2005; 11(5):306-10. PubMed ID: 16174149
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ductal carcinoma in situ treated with breast-conserving surgery and radiotherapy: a comparison with ECOG study 5194.
    Motwani SB; Goyal S; Moran MS; Chhabra A; Haffty BG
    Cancer; 2011 Mar; 117(6):1156-62. PubMed ID: 21381008
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Factors associated with optimal long-term cosmetic results in patients treated with accelerated partial breast irradiation using balloon-based brachytherapy.
    Vicini FA; Keisch M; Shah C; Goyal S; Khan AJ; Beitsch PD; Lyden M; Haffty BG
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):512-8. PubMed ID: 22079730
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sole brachytherapy of the tumor bed after conservative surgery for T1 breast cancer: five-year results of a phase I-II study and initial findings of a randomized phase III trial.
    Polgár C; Sulyok Z; Fodor J; Orosz Z; Major T; Takácsi-Nagy Z; Mangel LC; Somogyi A; Kásler M; Németh G
    J Surg Oncol; 2002 Jul; 80(3):121-8; discussion 129. PubMed ID: 12115793
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Partial breast irradiation for early breast cancer with favorable prognostic factors: 3-year results of the German-Austrian phase II-trial].
    Ott OJ; Pötter R; Hildebrandt G; Hammer J; Lotter M; Beckmann MW; Sauer R; Strnad V
    Rofo; 2005 Jul; 177(7):962-7. PubMed ID: 15973598
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hypofractionated whole-breast radiotherapy and concomitant boost after breast conservation in elderly patients.
    Cante D; Franco P; Sciacero P; Girelli G; Pasquino M; Casanova Borca V; Tofani S; Porta MR; Ricardi U
    Tumori; 2016; 102(2):196-202. PubMed ID: 26350199
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intensity modulated radiation therapy with simultaneous integrated boost in early breast cancer irradiation. Report of feasibility and preliminary toxicity.
    Fiorentino A; Mazzola R; Ricchetti F; Giaj Levra N; Fersino S; Naccarato S; Sicignano G; Ruggieri R; Di Paola G; Massocco A; Gori S; Alongi F
    Cancer Radiother; 2015 Aug; 19(5):289-94. PubMed ID: 26206732
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phase 2 trial of accelerated, hypofractionated whole-breast irradiation of 39 Gy in 13 fractions followed by a tumor bed boost sequentially delivering 9 Gy in 3 fractions in early-stage breast cancer.
    Kim JY; Jung SY; Lee S; Kang HS; Lee ES; Park IH; Lee KS; Ro J; Lee NK; Shin KH
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1037-42. PubMed ID: 24267970
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cosmesis, late sequelae and local control after breast-conserving therapy: influence of type of tumour bed boost and adjuvant chemotherapy.
    Budrukkar AN; Sarin R; Shrivastava SK; Deshpande DD; Dinshaw KA
    Clin Oncol (R Coll Radiol); 2007 Oct; 19(8):596-603. PubMed ID: 17706403
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Accelerated partial breast irradiation using interstitial high dose rate iridium brachytherapy: Early Australian experience and review of the literature.
    Stevens MJ; Cooper SG; Cross P; Wang Y
    Australas Radiol; 2006 Apr; 50(2):143-51. PubMed ID: 16635033
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intraoperative radiotherapy in early-stage breast cancer: results of the montpellier phase II trial.
    Lemanski C; Azria D; Gourgon-Bourgade S; Gutowski M; Rouanet P; Saint-Aubert B; Ailleres N; Fenoglietto P; Dubois JB
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):698-703. PubMed ID: 19467579
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term outcome with interstitial brachytherapy boost in the treatment of women with early-stage breast cancer.
    Neumanova R; Petera J; Frgala T; Dusek L; Jarkovsky J; Kuricka R
    Neoplasma; 2007; 54(5):413-23. PubMed ID: 17688371
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Breast-conservative surgery with close or positive margins: can the breast be preserved with high-dose-rate brachytherapy boost?
    Guinot JL; Roldan S; Maroñas M; Tortajada I; Carrascosa M; Chust ML; Estornell M; Mengual JL; Arribas L
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1381-7. PubMed ID: 17418974
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MammoSite accelerated partial breast irradiation: a single-institution outcomes analysis with 2 years of followup.
    Haley M; Beriwal S; Heron DE; Kim H; Falk J; Johnson R; Mogus R
    Brachytherapy; 2009; 8(1):9-13. PubMed ID: 18955020
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Factors associated with optimal cosmetic results at 36 months in patients treated with accelerated partial breast irradiation (APBI) on the American Society of Breast Surgeons (ASBrS) MammoSite Breast Brachytherapy Registry Trial.
    Goyal S; Khan AJ; Vicini F; Beitsch PD; Lyden M; Keisch M; Haffty BG
    Ann Surg Oncol; 2009 Sep; 16(9):2450-8. PubMed ID: 19517191
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tumor bed boost omission after negative re-excision in breast-conservation treatment.
    Arthur DW; Cuttino LW; Neuschatz AC; Koo DT; Morris MM; Bear HD; Kaplan BJ; Dawson K; Wazer DE
    Ann Surg Oncol; 2006 Jun; 13(6):794-801. PubMed ID: 16614879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.